These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34446472)

  • 1. Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study.
    Oh H; Wild RA; Manson JE; Bea JW; Shadyab AH; Pfeiffer RM; Saquib N; Underland L; Anderson GL; Xu X; Trabert B
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2018-2029. PubMed ID: 34446472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recreational Physical Activity, Sitting, and Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study.
    Oh H; Saquib N; Ochs-Balcom HM; Pfeiffer RM; Richey PA; Shadyab AH; Wild RA; Underland L; Anderson GL; Xu X; Trabert B
    Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):97-107. PubMed ID: 34663616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.
    Oh H; Coburn SB; Matthews CE; Falk RT; LeBlanc ES; Wactawski-Wende J; Sampson J; Pfeiffer RM; Brinton LA; Wentzensen N; Anderson GL; Manson JE; Chen C; Zaslavsky O; Xu X; Trabert B
    Breast Cancer Res; 2017 Mar; 19(1):28. PubMed ID: 28284224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
    Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study.
    Trabert B; Michels KA; Anderson GL; Brinton LA; Falk RT; Geczik AM; Harris HR; Pan K; Pfeiffer RM; Qi L; Rohan T; Wentzensen N; Xu X
    Int J Cancer; 2019 Oct; 145(8):2051-2060. PubMed ID: 30684389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study.
    Geczik AM; Falk RT; Xu X; Ansong D; Yarney J; Wiafe-Addai B; Edusei L; Dedey F; Vanderpuye V; Titiloye N; Adjei E; Aitpillah F; Osei-Bonsu E; Oppong J; Biritwum R; Nyarko K; Wiafe S; Awuah B; Clegg-Lamptey JN; Ahearn TU; Figueroa J; Garcia-Closas M; Brinton LA; Trabert B
    Breast Cancer Res; 2022 Jan; 24(1):9. PubMed ID: 35081987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C; Labrie F; Archer DF; Ke Y; Gonthier R; Simard JN; Lavoie L; Vaillancourt M; Montesino M; Balser J; Moyneur É;
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a correlation between androgens and sexual desire in women?
    Wåhlin-Jacobsen S; Pedersen AT; Kristensen E; Laessøe NC; Lundqvist M; Cohen AS; Hougaard DM; Giraldi A
    J Sex Med; 2015 Feb; 12(2):358-73. PubMed ID: 25475395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women.
    Stanczyk FZ; Chaikittisilpa S; Sriprasert I; Rafatnia A; Nadadur M; Mishell DR
    Climacteric; 2019 Apr; 22(2):169-174. PubMed ID: 30612472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women.
    Labrie F; Bélanger A; Bélanger P; Bérubé R; Martel C; Cusan L; Gomez J; Candas B; Castiel I; Chaussade V; Deloche C; Leclaire J
    J Steroid Biochem Mol Biol; 2006 Jun; 99(4-5):182-8. PubMed ID: 16621522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women.
    Danforth KN; Eliassen AH; Tworoger SS; Missmer SA; Barbieri RL; Rosner BA; Colditz GA; Hankinson SE
    Int J Cancer; 2010 Jan; 126(1):199-207. PubMed ID: 19569181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.
    Hsing AW; Stanczyk FZ; Bélanger A; Schroeder P; Chang L; Falk RT; Fears TR
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1004-8. PubMed ID: 17507629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
    Ke Y; Labrie F; Gonthier R; Simard JN; Bergeron D; Martel C; Vaillancourt M; Montesino M; Lavoie L; Archer DF; Balser J; Moyneur E;
    J Steroid Biochem Mol Biol; 2015 Nov; 154():186-96. PubMed ID: 26291918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal cutoffs of obesity measures in relation to cancer risk in postmenopausal women in the Women's Health Initiative Study.
    Heo M; Kabat GC; Strickler HD; Lin J; Hou L; Stefanick ML; Anderson GL; Rohan TE
    J Womens Health (Larchmt); 2015 Mar; 24(3):218-27. PubMed ID: 25587642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA.
    Labrie F; Cusan L; Gomez JL; Martel C; Bérubé R; Bélanger P; Chaussade V; Deloche C; Leclaire J
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):1-9. PubMed ID: 18359622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ; Azen CG; Pike MC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.